Inter Pharma Public Company Limited
Inter Pharma Public Company Limited manufactures, imports, and distributes drug and dietary supplement products for humans and animals in Thailand. It operates through three segments: Human healthcare, Animal healthcare, and Hospital and clinics. The company offers healthcare, anti-aging, and human beauty products, such as medical supplies, nutrition therapy, cosmetics, supplementary food, probio… Read more
Inter Pharma Public Company Limited (IP) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.036x
Based on the latest financial reports, Inter Pharma Public Company Limited (IP) has a cash flow conversion efficiency ratio of 0.036x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (฿81.06 Million) by net assets (฿2.26 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Inter Pharma Public Company Limited - Cash Flow Conversion Efficiency Trend (2016–2024)
This chart illustrates how Inter Pharma Public Company Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Inter Pharma Public Company Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Inter Pharma Public Company Limited ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Agile Content SA
MC:AGIL
|
-0.035x |
|
Bcl Industries Limited
NSE:BCLIND
|
0.021x |
|
PT Wintermar Offshore Marine Tbk
F:W6O
|
0.027x |
|
Heran Co Ltd
TW:5283
|
0.153x |
|
Astec LifeSciences Limited
NSE:ASTEC
|
-0.020x |
|
Osmanli Menkul Degerler AS
IS:OSMEN
|
-0.129x |
|
BLS E-Services Limited
NSE:BLSE
|
N/A |
|
Woongjin Thinkbig Co Ltd
KO:095720
|
0.118x |
Annual Cash Flow Conversion Efficiency for Inter Pharma Public Company Limited (2016–2024)
The table below shows the annual cash flow conversion efficiency of Inter Pharma Public Company Limited from 2016 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ฿2.15 Billion | ฿177.84 Million | 0.083x | +43.99% |
| 2023-12-31 | ฿2.12 Billion | ฿121.42 Million | 0.057x | -16.91% |
| 2022-12-31 | ฿2.07 Billion | ฿143.09 Million | 0.069x | +230.05% |
| 2021-12-31 | ฿783.50 Million | ฿-41.57 Million | -0.053x | -193.49% |
| 2020-12-31 | ฿487.68 Million | ฿-8.82 Million | -0.018x | -267.26% |
| 2019-12-31 | ฿465.74 Million | ฿5.03 Million | 0.011x | +118.69% |
| 2018-12-31 | ฿106.99 Million | ฿-6.19 Million | -0.058x | -139.76% |
| 2017-12-31 | ฿78.74 Million | ฿11.46 Million | 0.145x | -78.64% |
| 2016-12-31 | ฿36.97 Million | ฿25.19 Million | 0.681x | -- |